July 14 2023, David R Brown
IMCD acquires O&3, an industry leading innovative natural ingredients supplier
Leading distributor and formulator of speciality chemicals and ingredients, IMCD have acquired 90% of the shares in O&3 Limited, an industry leading supplier of speciality natural ingredients to the global beauty and personal care markets.
The activities of IMCD and O&3 are highly complementary and will strengthen both companies
Paul Hanbury
Managing Director of IMCD UK
Founded in 2018, harnessing decades of family legacy within the sector, O&3 has established itself as a global leader in the speciality natural ingredients sector. O&3 has delivered impressive growth since its inception via the production, marketing, and formulation of an extensive range of conventional and organic natural ingredients for the beauty and personal care markets. With its expansive global supply chain, O&3 also boasts a diverse client portfolio from notable indie brands, through to major global brands, manufacturers, and retailers.
O&3's clear global growth ambitions, paired with IMCD's international scale and established infrastructure, makes the two businesses an ideal fit. With 69 employees, across its offices and facilities in Ripon (UK), Warka (Poland) and New York (USA), O&3 generated revenue of approximately EUR 37 million in the financial year that ended on March 31, 2023.
“The activities of IMCD and O&3 are highly complementary and will strengthen both companies. We share a culture of being reliable partners to both suppliers and customers by offering technical expertise and formulation support and solutions for supply chain challenges,” said Paul Hanbury, Managing Director IMCD UK.
“With its impressive track record for supporting entrepreneurial businesses to further scale and fulfil ambitious growth strategies, IMCD is the ideal cultural and strategic partner for O&3. We, the co-founders, are incredibly proud of what O&3 has achieved and are equally energised for the next chapter with the wider IMCD team. Our vision to quickly expand our global footprint whilst maintaining best-in-class ingredients and service for our clients will continue to be our core focus. We are absolutely confident that with O&3's expertise in the naturals sector and IMCD's global infrastructure, this partnership promises to be an incredibly exciting journey for the company, our people and our wider stakeholders,” said Thomas Kerfoot, co-founder & commercial director, O&3 Limited.
About IMCD N.V.
IMCD is a market-leader in the sales, marketing, and distribution of speciality chemicals and ingredients. Its result-driven professionals
provide market-focused solutions to suppliers and customers across EMEA, Americas and Asia-Pacific, offering a range of comprehensive product
portfolios, including innovative formulations that embrace industry trends.
Listed at Euronext, Amsterdam (IMCD), IMCD realised revenues of EUR 4,601 million in 2022 with nearly 4,323 employees in over 50 countries, working from 109 offices spanning 6 continents. IMCD's dedicated team of technical and commercial experts work in close partnership to tailor best-in-class solutions and provide value through expertise for around 60,000 customers and a diverse range of world class suppliers.
Source(s): IMCD Press Release
Further Information
Visit: https://www.imcdgroup.com